These findings contributed to stressing the hypothesis that COPD could be considered a disease of accelerated aging and underline the potential of SIRT1 as valid therapeutic target to treat respiratory disorders sharing chronic inflammation. This evidence concerns the gene SIRT1 and chronic obstructive pulmonary disease.